Sangamo, Genentech in Development Pact - Forbes.com: "Sangamo BioSciences Inc., a developer of gene-based therapies, said Monday it entered an agreement to provide Genentech Inc. with technology to make protein drugs.
Financial terms were not disclosed.
Under the agreement, Sangamo will provide Genentech (nyse: DNA - news - people ) with its zinc finger DNA-binding protein technology and make enzymes for Genentech to evaluate for drug development."
